Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CHEMOMAB LTD.”

4 pharma patents match "CHEMOMAB LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "CHEMOMAB LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “CHEMOMAB LTD.” · 30,257 patents in full index Clear search

  1. US 12018074

    Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

    CHEMOMAB LTD. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  2. US 11365246

    Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases

    CHEMOMAB LTD. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  3. US 10479830

    Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

    CHEMOMAB LTD. · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  4. US 10246508

    Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

    CHEMOMAB LTD. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted